Résultats de la recherche - 84 results
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
Publication Type: Peer reviewed scientific article Authors: Rose, Angela MC; Nicolay, Nathalie; Sandonis Martín, Virginia; Mazagatos, Clara; Petrović, Goranka; Niessen, F Annabel; Machado, Ausenda; Launay, Odile; Sarah Denayer; Seyler, Lucie; Baruch, Joaq ...
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions.
Publication Type: Peer reviewed scientific article Authors: Meyer Sauteur, Patrick M; Beeton, Michael L; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMA ...
Identification and characterization of inorganic food additives and pearlescent pigments in sprays for food decoration by STEM-EDX
products and domestic cooking to enhance the appearance of food. To obtain specific hues, inorganic food additives containing (nano)particles are mixed in varying concentrations, and pearlescent pigments ...
Training on the assessment of quality part (M3) of the eCTD for the registration of vaccines for human use
Service: Qualité des vaccins et produits sanguins Kwaliteit van vaccins en bloedproducten Quality of vaccines and blood products Full text language: English Category: C31 FOS Classification: 3.03 Health ...
The phage-encoded PIT4 protein affects multiple two-component systems of Pseudomonas aeruginosa
the development of an anti-virulence compound that targets the bacterial TCS. Health Topics: Effectiveness and safety of vaccines, medicines and health products- Quality of medical laboratories ...
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium
Publication Type: Peer reviewed scientific article Authors: Elias Vermeiren; Joris Van Loenhout; Léonore Nasiadka; Veerle Stouten; Matthieu Billuart; Izaak Van Evercooren; Lucy Catteau; Pierre Hubin Source: BMC Res Notes, Volume 16, Issue 1 (2023) Keyword ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Publication Type: Peer reviewed scientific article Authors: Kislaya, Irina; Sentís, Alexis; Starrfelt, Jostein; Nunes, Baltazar; Martínez-Baz, Iván; Nielsen, Katrine Finderup; AlKerwi, Ala'a; Toon Braeye; Fontán-Vela, Mario; Bacci, Sabrina; Meijerink ...
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Publication Type: Peer reviewed scientific article Authors: Meslé, Margaux M I; Sinnathamby, Mary; Mook, Piers; WHO European Region Respiratory Network Group; Pebody, Richard; Lakhani, Anissa; Zambon, Maria; Popovici, Odette; Lazar, Mihaela; Ljubović, Ame ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
last PSV dose). We measured VE overall, by vaccine category/product, age group and time since first mRNA booster dose, adjusting by site as a fixed effect, and by swab date, age, sex, and ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
SARI patients ≥ 20 years with symptom onset ≥ 150 days from last PSV dose, VE for complete Comirnaty PSV was 54% (95% CI: 18-74). Among those receiving Comirnaty PSV and mRNA booster (any product) ≥ 150 ...